Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020

Licia Bordi, Emanuele Nicastri, Laura Scorzolini, Antonino Di Caro, Maria Rosaria Capobianchi, Concetta Castilletti, Eleonora Lalle, Behalf Of Inmi Covid-Study Group On Behalf Of Inmi Covid-Study Group

Research output: Contribution to journalArticle

Abstract

A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Volume25
Issue number8
DOIs
Publication statusPublished - Feb 1 2020

    Fingerprint

Keywords

  • differential diagnosis
  • rapid molecular assay
  • respiratory pathogens
  • SARS-CoV-2

ASJC Scopus subject areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health
  • Virology

Cite this